首页 > 最新文献

Kurume Medical Journal最新文献

英文 中文
The Assessment of Airway Compression Due to Cervical Fusion in Klippel-Feil Syndrome Patients: A Report of Two Cases. Klippel-Feil 综合征患者颈椎融合术导致气道受压的评估:两个病例的报告
Q4 Medicine Pub Date : 2024-07-02 Epub Date: 2024-05-17 DOI: 10.2739/kurumemedj.MS7012009
Shosaburo Jotaki, Hiroko Taniguchi, Haruka Miyakawa, Teruyuki Hiraki

In general anesthesia for Klippel-Feil syndrome (KFS) patients, there is a potential risk of difficult intubation. However, airway assessment to predict difficult intubation for KFS patients is not known. In Patient 1, cervical spine computed tomography (CT) revealed airway compression due to cervical fusion. For airway assessment, bronchofiberscopy, three-dimensional (3-D) CT, and virtual bronchoscopic image (VBI) construction were performed. Based on these images, fiberoptic nasotracheal awake intubation was performed. In Patient 2, magnetic resonance imaging and bronchofiberscopy showed no airway compression due to cervical fusion; therefore, tracheal intubation was performed using a video laryngoscope after anesthetic administration. Airway compression due to cervical fusion is considered one of the risk factors for difficult intubation in KFS patients.

在对 Klippel-Feil 综合征(KFS)患者进行全身麻醉时,可能存在插管困难的潜在风险。然而,预测 KFS 患者插管困难的气道评估尚不清楚。在患者 1 中,颈椎计算机断层扫描(CT)显示颈椎融合术导致气道受压。为评估气道,进行了支气管纤维检查、三维 CT 和虚拟支气管镜图像(VBI)构建。根据这些图像,进行了纤支镜鼻气管清醒插管。在患者 2 中,磁共振成像和支气管纤维镜检查显示颈椎融合术没有导致气道受压,因此在注射麻醉剂后使用视频喉镜进行了气管插管。颈椎融合导致的气道受压被认为是 KFS 患者插管困难的风险因素之一。
{"title":"The Assessment of Airway Compression Due to Cervical Fusion in Klippel-Feil Syndrome Patients: A Report of Two Cases.","authors":"Shosaburo Jotaki, Hiroko Taniguchi, Haruka Miyakawa, Teruyuki Hiraki","doi":"10.2739/kurumemedj.MS7012009","DOIUrl":"10.2739/kurumemedj.MS7012009","url":null,"abstract":"<p><p>In general anesthesia for Klippel-Feil syndrome (KFS) patients, there is a potential risk of difficult intubation. However, airway assessment to predict difficult intubation for KFS patients is not known. In Patient 1, cervical spine computed tomography (CT) revealed airway compression due to cervical fusion. For airway assessment, bronchofiberscopy, three-dimensional (3-D) CT, and virtual bronchoscopic image (VBI) construction were performed. Based on these images, fiberoptic nasotracheal awake intubation was performed. In Patient 2, magnetic resonance imaging and bronchofiberscopy showed no airway compression due to cervical fusion; therefore, tracheal intubation was performed using a video laryngoscope after anesthetic administration. Airway compression due to cervical fusion is considered one of the risk factors for difficult intubation in KFS patients.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"73-75"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141066195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy. 接受新辅助化疗的晚期卵巢癌患者的化疗反应评分与多药耐药性1和CA125 ELIMination Rate常数K的关系
Q4 Medicine Pub Date : 2024-07-02 Epub Date: 2024-03-29 DOI: 10.2739/kurumemedj.MS7012004
Ken Matsukuma, Shin Nishio, Shingo Tasaki, Jongmyung Park, Hiroki Nasu, Teruyuki Yoshimitsu, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Sakiko Sanada, Kimio Ushijima

Aim: The relationship between chemotherapy response score (CRS), a widely used response predictor of neoadjuvant chemotherapy-interval debulking surgery (NAC-IDS), and multidrug resistance 1 (MDR1) and CA125 ELIMination rate constant K (KELIM), is undetermined. We evaluated CRS in advanced ovarian cancer patients undergoing NAC and looked for associations between CRS and MDR1 and CA125 KELIM. Our aim was to predict the therapeutic effect of NAC before interval debulking surgery (IDS) by examining its association with CRS.

Methods: This retrospective cohort study included patients who underwent NAC-IDS (first-line treatment) at Kurume University Hospital, Japan, between 2004 and 2017. CRS association with MDR1 and CA125 KELIM was examined using Cox proportional hazard regression analyses. Survival curves used Kaplan-Meier method, and survival differences between groups used log-rank test.

Results: Overall, 55 patients were classified into CRS1 (n=22), CRS2 (n=19), and CRS3 (n=14). The CRS3 group had a significantly better prognosis than the CRS1 or CRS2 group. CRS, age, and IDS status were clinical prognostic factors for ovarian cancer. MDR1 positivity for excision repair cross-complementing group 1, β-tubulin, and Y-box binding protein-1 occurred in 15, 17, and 11 patients, respectively, but these were not associated with CRS. CA125 KELIM was <0.5 (n=8), 0.5-1.0 (n=30), and ≥ 1.0 (n=17) but not associated with CRS.

Conclusion: CRS is reconfirmed as a treatment response predictor for NAC-IDS, but its association with drug resistance factors remains unconfirmed.

目的:化疗反应评分(CRS)是广泛应用的新辅助化疗-间期剥离手术(NAC-IDS)反应预测指标,它与多药耐药性1(MDR1)和CA125 ELIMination速率常数K(KELIM)之间的关系尚未确定。我们评估了接受 NAC 的晚期卵巢癌患者的 CRS,并寻找 CRS 与 MDR1 和 CA125 KELIM 之间的关联。我们的目的是通过研究NAC与CRS的关系,预测间期去势手术(IDS)前NAC的治疗效果:这项回顾性队列研究纳入了 2004 年至 2017 年期间在日本久留米大学医院接受 NAC-IDS (一线治疗)的患者。采用 Cox 比例危险回归分析研究了 CRS 与 MDR1 和 CA125 KELIM 的关系。生存曲线采用 Kaplan-Meier 法,组间生存差异采用 log-rank 检验:55名患者被分为CRS1组(22人)、CRS2组(19人)和CRS3组(14人)。CRS3组的预后明显优于CRS1或CRS2组。CRS、年龄和IDS状态是卵巢癌的临床预后因素。切除修复交叉互补组1、β-微管蛋白和Y-盒结合蛋白-1的MDR1阳性分别出现在15、17和11例患者中,但这些与CRS无关。CA125 KELIM 为 结论:CRS再次被证实是NAC-IDS治疗反应的预测指标,但其与耐药因素的关系仍未得到证实。
{"title":"Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.","authors":"Ken Matsukuma, Shin Nishio, Shingo Tasaki, Jongmyung Park, Hiroki Nasu, Teruyuki Yoshimitsu, Kazuto Tasaki, Takahiro Katsuda, Atsumu Terada, Naotake Tsuda, Sakiko Sanada, Kimio Ushijima","doi":"10.2739/kurumemedj.MS7012004","DOIUrl":"10.2739/kurumemedj.MS7012004","url":null,"abstract":"<p><strong>Aim: </strong>The relationship between chemotherapy response score (CRS), a widely used response predictor of neoadjuvant chemotherapy-interval debulking surgery (NAC-IDS), and multidrug resistance 1 (MDR1) and CA125 ELIMination rate constant K (KELIM), is undetermined. We evaluated CRS in advanced ovarian cancer patients undergoing NAC and looked for associations between CRS and MDR1 and CA125 KELIM. Our aim was to predict the therapeutic effect of NAC before interval debulking surgery (IDS) by examining its association with CRS.</p><p><strong>Methods: </strong>This retrospective cohort study included patients who underwent NAC-IDS (first-line treatment) at Kurume University Hospital, Japan, between 2004 and 2017. CRS association with MDR1 and CA125 KELIM was examined using Cox proportional hazard regression analyses. Survival curves used Kaplan-Meier method, and survival differences between groups used log-rank test.</p><p><strong>Results: </strong>Overall, 55 patients were classified into CRS1 (n=22), CRS2 (n=19), and CRS3 (n=14). The CRS3 group had a significantly better prognosis than the CRS1 or CRS2 group. CRS, age, and IDS status were clinical prognostic factors for ovarian cancer. MDR1 positivity for excision repair cross-complementing group 1, β-tubulin, and Y-box binding protein-1 occurred in 15, 17, and 11 patients, respectively, but these were not associated with CRS. CA125 KELIM was <0.5 (n=8), 0.5-1.0 (n=30), and ≥ 1.0 (n=17) but not associated with CRS.</p><p><strong>Conclusion: </strong>CRS is reconfirmed as a treatment response predictor for NAC-IDS, but its association with drug resistance factors remains unconfirmed.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"29-37"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140332110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Clinical Course in a Population of Patients with Biliary Tract Cancer Diagnosed as Unresectable After Portal Vein Embolization: A Case Series. 门静脉栓塞术后诊断为不可切除的胆管癌患者临床病程分析:病例系列。
Q4 Medicine Pub Date : 2024-07-02 Epub Date: 2024-03-19 DOI: 10.2739/kurumemedj.MS7012001
Hajime Imamura, Tomohiko Adachi, Hajime Matsushima, Hideki Ishimaru, Masayuki Fukumoto, Kyohei Yoshino, Kunihiro Matsuguma, Ryo Matsumoto, Takanobu Hara, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi

Portal vein embolization (PVE) is recommended as a preoperative procedure for patients with biliary tract cancer scheduled to undergo hepatic resection of more than 50%-60% of the liver. However, details and/or information regarding the follow-up of unresectable cases are often lacking, and the clinical course of unresectable cases is not well analyzed and reported. This study aimed to clarify the clinical prognosis of patients with unresectable biliary tract cancer after PVE. We retrospectively analyzed the clinical backgrounds of patients with biliary tract cancer who underwent PVE without subsequent resection between January 2011 and October 2022. Of the 21 patients with biliary tract cancer who underwent PVE during the study period, eight (38%) cases were unsuitable for resection after PVE for the following reasons: intraoperatively detected dissemination (n=2), para-aortic lymph node metastasis (n=1), liver metastasis (n=1), decreased liver function (n=2), development of liver metastasis while waiting (n=1), and insufficient residual liver volume (n=1). All patients received subsequent chemotherapy, including gemcitabine plus S-1 therapy in three cases, gemcitabine plus cisplatin plus S-1 in three cases, and gemcitabine plus cisplatin or S-1+cisplatin in one case each. As there is currently no curative treatment for biliary tract cancer other than surgery, multidisciplinary management and treatment of patient factors, including tumor factors and liver function, are essential to reducing the number of unresectable cases after PVE.

门静脉栓塞术(PVE)被推荐作为胆道癌患者的术前手术,计划对超过50%-60%的肝脏进行肝切除。然而,关于无法切除病例的随访细节和/或信息往往缺乏,对无法切除病例的临床过程也没有很好的分析和报告。本研究旨在明确PVE术后不可切除胆道癌患者的临床预后。我们回顾性分析了2011年1月至2022年10月期间接受PVE治疗但未进行后续切除术的胆道癌患者的临床背景。在研究期间接受PVE的21例胆道癌患者中,有8例(38%)不适合在PVE后进行切除,原因如下:术中发现扩散(2例)、主动脉旁淋巴结转移(1例)、肝转移(1例)、肝功能减退(2例)、等待期间出现肝转移(1例)和残肝体积不足(1例)。所有患者均接受了后续化疗,其中吉西他滨加S-1治疗3例,吉西他滨加顺铂加S-1治疗3例,吉西他滨加顺铂或S-1+顺铂治疗各1例。由于胆道癌目前除手术治疗外没有其他根治性治疗方法,因此多学科管理和患者因素(包括肿瘤因素和肝功能)治疗对于减少 PVE 后无法切除病例的数量至关重要。
{"title":"Analysis of the Clinical Course in a Population of Patients with Biliary Tract Cancer Diagnosed as Unresectable After Portal Vein Embolization: A Case Series.","authors":"Hajime Imamura, Tomohiko Adachi, Hajime Matsushima, Hideki Ishimaru, Masayuki Fukumoto, Kyohei Yoshino, Kunihiro Matsuguma, Ryo Matsumoto, Takanobu Hara, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi","doi":"10.2739/kurumemedj.MS7012001","DOIUrl":"10.2739/kurumemedj.MS7012001","url":null,"abstract":"<p><p>Portal vein embolization (PVE) is recommended as a preoperative procedure for patients with biliary tract cancer scheduled to undergo hepatic resection of more than 50%-60% of the liver. However, details and/or information regarding the follow-up of unresectable cases are often lacking, and the clinical course of unresectable cases is not well analyzed and reported. This study aimed to clarify the clinical prognosis of patients with unresectable biliary tract cancer after PVE. We retrospectively analyzed the clinical backgrounds of patients with biliary tract cancer who underwent PVE without subsequent resection between January 2011 and October 2022. Of the 21 patients with biliary tract cancer who underwent PVE during the study period, eight (38%) cases were unsuitable for resection after PVE for the following reasons: intraoperatively detected dissemination (n=2), para-aortic lymph node metastasis (n=1), liver metastasis (n=1), decreased liver function (n=2), development of liver metastasis while waiting (n=1), and insufficient residual liver volume (n=1). All patients received subsequent chemotherapy, including gemcitabine plus S-1 therapy in three cases, gemcitabine plus cisplatin plus S-1 in three cases, and gemcitabine plus cisplatin or S-1+cisplatin in one case each. As there is currently no curative treatment for biliary tract cancer other than surgery, multidisciplinary management and treatment of patient factors, including tumor factors and liver function, are essential to reducing the number of unresectable cases after PVE.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"77-81"},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual Assessment of Therapeutic Relationships in Psychiatric Patients: A Pilot Study Using the Pictorial Representation of Illness and Self Measure. 精神病患者治疗关系的视觉评估:使用 "疾病和自我测量的图画表现 "进行试点研究。
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934005
Kiyoshi Naganuma, Misari Oe, Tetsuya Ishida, Yudai Kobayashi, Hiromi Chiba, Michiko Matsuoka, Motohiro Ozone

Background: Although the therapeutic relationship (or 'alliance') is well known to be a key component of psychiatric treatment, there has been no simple way to objectively measure the patient-therapist relationship. Here, we measured the psychological distance between patients and their therapists by using the Pictorial Representation of Illness and Self Measure (PRISM).

Patients and methods: We analyzed the patient-therapist relationship of 112 patients from two hospitals in Japan (54 males, 57 females, 1 unknown; age 46.20 ± 15.03 years [mean ± SD]) who completed the PRISM and self report questionnaires (LSNS-6, K6, and BASIS-32) about their social network, psychological distress, and outcomes of mental health treatment.

Results: PRISM measurements were available for all patients who consented to participate. In the comparison by disease category, schizophrenia recorded the closest distance to the psychiatrist in charge, followed by bipolar disorder, depression, and neurotic disorder. Regarding the distance to the psychiatrist in charge, PRISM showed a weak negative correlation (r = -0.23, p < 0.05) with age, indicating that with increasing age, the therapeutic rela tionship was more important to the patients.

Conclusion: Our findings indicate the possibility of implementing PRISM to assess the impact of the therapeutic relationship in patients with a wide range of psychiatric disorders, and they suggest that PRISM holds great potential for clinical application.

背景:尽管众所周知治疗关系(或 "联盟")是精神病治疗的关键组成部分,但一直没有一种简单的方法来客观衡量患者与治疗师之间的关系。在此,我们使用疾病与自我表象测量法(PRISM)测量了患者与治疗师之间的心理距离:我们分析了来自日本两家医院的 112 名患者(54 名男性,57 名女性,1 名未知;年龄 46.20 ± 15.03 岁 [平均 ± SD])的患者与治疗师之间的关系,这些患者填写了 PRISM 和自我报告问卷(LSNS-6、K6 和 BASIS-32),内容涉及他们的社交网络、心理困扰和心理健康治疗的结果:所有同意参与的患者都接受了 PRISM 测量。在按疾病类别进行的比较中,精神分裂症患者与主管精神科医生的距离最近,其次是双相情感障碍、抑郁症和神经症。在与主管精神科医生的距离方面,PRISM 与年龄呈弱负相关(r = -0.23,p < 0.05),这表明随着年龄的增长,治疗关系对患者更为重要:我们的研究结果表明,PRISM 可用于评估治疗关系对各种精神障碍患者的影响,并表明 PRISM 在临床应用方面具有巨大潜力。
{"title":"Visual Assessment of Therapeutic Relationships in Psychiatric Patients: A Pilot Study Using the Pictorial Representation of Illness and Self Measure.","authors":"Kiyoshi Naganuma, Misari Oe, Tetsuya Ishida, Yudai Kobayashi, Hiromi Chiba, Michiko Matsuoka, Motohiro Ozone","doi":"10.2739/kurumemedj.MS6934005","DOIUrl":"10.2739/kurumemedj.MS6934005","url":null,"abstract":"<p><strong>Background: </strong>Although the therapeutic relationship (or 'alliance') is well known to be a key component of psychiatric treatment, there has been no simple way to objectively measure the patient-therapist relationship. Here, we measured the psychological distance between patients and their therapists by using the Pictorial Representation of Illness and Self Measure (PRISM).</p><p><strong>Patients and methods: </strong>We analyzed the patient-therapist relationship of 112 patients from two hospitals in Japan (54 males, 57 females, 1 unknown; age 46.20 ± 15.03 years [mean ± SD]) who completed the PRISM and self report questionnaires (LSNS-6, K6, and BASIS-32) about their social network, psychological distress, and outcomes of mental health treatment.</p><p><strong>Results: </strong>PRISM measurements were available for all patients who consented to participate. In the comparison by disease category, schizophrenia recorded the closest distance to the psychiatrist in charge, followed by bipolar disorder, depression, and neurotic disorder. Regarding the distance to the psychiatrist in charge, PRISM showed a weak negative correlation (r = -0.23, p < 0.05) with age, indicating that with increasing age, the therapeutic rela tionship was more important to the patients.</p><p><strong>Conclusion: </strong>Our findings indicate the possibility of implementing PRISM to assess the impact of the therapeutic relationship in patients with a wide range of psychiatric disorders, and they suggest that PRISM holds great potential for clinical application.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"159-165"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Analysis for Potential Hospital-Acquired Infection Caused by Aspergillus Tubingensis Through the Environment. 通过环境对管曲霉引起的潜在医院感染进行分子分析。
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934013
Chiyoko Tanamachi, Jun Iwahashi, Akinobu Togo, Keisuke Ohta, Miho Miura, Toru Sakamoto, Kenji Gotoh, Rie Horita, Katsuhiko Kamei, Hiroshi Watanabe

The identification of Aspergillus species has been performed mainly by morphological classification. In recent years, however, the revelation of the existence of cryptic species has required genetic analysis for accurate identification. The purpose of this study was to investigate five Aspergillus section Nigri strains isolated from a patient and the environment in a university hospital. Species identification by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry identified all five black Aspergillus strains as Aspergillus niger. However, calmodulin gene sequence analysis revealed that all five strains were cryptic species, four of which, including the clinical strain, were Aspergillus tubingensis. Hospital-acquired infection of the patient with the A. tubingensis strain introduced from the environment was suspected, but sequencing of six genes from four A. tubingensis strains revealed no environmental strain that completely matched the patient strain. The amount of in vitro biofilm formation of the four examples of the A. tubingensis strain was comparable to that of Aspergillus fumigatus. An extracellular matrix was observed by electron microscopy of the biofilm of the clinical strain. This study suggests that various types of biofilm-forming A. tubingensis exist in the hospital environment and that appropriate environmental management is required.

曲霉菌种的鉴定主要是通过形态学分类进行的。但近年来,由于发现了隐蔽菌种的存在,因此需要通过基因分析来准确鉴定。本研究的目的是调查从大学医院的一名患者和环境中分离出的五株 Nigri 曲霉。通过基质辅助激光解吸附/电离飞行时间质谱法进行菌种鉴定,发现五株黑曲霉均为黑曲霉。然而,钙调蛋白基因序列分析表明,所有五株菌株均为隐性菌种,其中四株(包括临床菌株)为管曲霉(Aspergillus tubingensis)。有人怀疑病人在医院感染了从环境中引入的管曲霉菌株,但对四株管曲霉菌株的六个基因进行测序后发现,环境中的菌株与病人的菌株并不完全匹配。四种管曲霉菌株在体外形成生物膜的数量与烟曲霉相当。通过电子显微镜观察,临床菌株的生物膜中存在细胞外基质。这项研究表明,医院环境中存在各种类型的管曲霉生物膜,需要进行适当的环境管理。
{"title":"Molecular Analysis for Potential Hospital-Acquired Infection Caused by Aspergillus Tubingensis Through the Environment.","authors":"Chiyoko Tanamachi, Jun Iwahashi, Akinobu Togo, Keisuke Ohta, Miho Miura, Toru Sakamoto, Kenji Gotoh, Rie Horita, Katsuhiko Kamei, Hiroshi Watanabe","doi":"10.2739/kurumemedj.MS6934013","DOIUrl":"10.2739/kurumemedj.MS6934013","url":null,"abstract":"<p><p>The identification of Aspergillus species has been performed mainly by morphological classification. In recent years, however, the revelation of the existence of cryptic species has required genetic analysis for accurate identification. The purpose of this study was to investigate five Aspergillus section Nigri strains isolated from a patient and the environment in a university hospital. Species identification by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry identified all five black Aspergillus strains as Aspergillus niger. However, calmodulin gene sequence analysis revealed that all five strains were cryptic species, four of which, including the clinical strain, were Aspergillus tubingensis. Hospital-acquired infection of the patient with the A. tubingensis strain introduced from the environment was suspected, but sequencing of six genes from four A. tubingensis strains revealed no environmental strain that completely matched the patient strain. The amount of in vitro biofilm formation of the four examples of the A. tubingensis strain was comparable to that of Aspergillus fumigatus. An extracellular matrix was observed by electron microscopy of the biofilm of the clinical strain. This study suggests that various types of biofilm-forming A. tubingensis exist in the hospital environment and that appropriate environmental management is required.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"185-193"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated with Perioperative Edema in Patients with Stage I Gastric Cancer Using a Body Composition Analyzer. 使用身体成分分析仪分析胃癌 I 期患者围手术期水肿的相关因素。
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934010
Yuki Umetani, Keishiro Aoyagi, Hideaki Kaku, Yuya Tanaka, Taizan Minami, Taro Isobe, Junya Kizaki, Naotaka Murakami, Fumihiko Fujita, Yoshito Akagi

Purpose: Assessment of nutritional status and nutritional interventions is important in gastric cancer patients. We investigated the factors associated with perioperative edema in patients with stage I gastric cancer using a body composition analyzer.

Methods: The study included 106 patients with stage I gastric cancer who underwent distal gastrectomy. The body composition of each patient was evaluated by bioelectrical impedance analysis (BIA) using an InBody 720 body composition analyzer. Patients with an extracellular water to total body water ratio of ≥ 0.4 before and 1 week after gastrectomy were considered to have edema, the cause of which was determined retrospectively.

Results: Patients with preoperative edema were significantly older, had a significantly higher lymph node metastasis rate and disease stage, and had a significantly poorer Controlling Nutritional Status (CONUT) score, and Prognostic Nutritional Index (PNI) compared with patients without preoperative edema. The group with postoperative edema had significantly higher proportions of elderly and female patients as well as a higher rate of Billroth-II reconstruction compared with the group without postoperative edema. The group with postoperative edema also had significantly lower intracellular water content, total body water content, protein content, skeletal muscle mass, and PNI.

Conclusions: Preoperative edema occurs in elderly patients with poor nutritional status, and postoperative edema occurs in elderly patients with a shorter operative time. Perioperative edema status assessed by BIA is thought to be related to perioperative nutritional status.

目的:对胃癌患者进行营养状况评估和营养干预非常重要。我们使用身体成分分析仪调查了与 I 期胃癌患者围手术期水肿相关的因素:研究包括 106 名接受远端胃切除术的 I 期胃癌患者。使用 InBody 720 身体成分分析仪通过生物电阻抗分析 (BIA) 评估了每位患者的身体成分。胃切除术前和术后一周,细胞外水分与全身水分之比≥0.4的患者被认为患有水肿,水肿的原因是通过回顾性分析确定的:结果:与术前无水肿的患者相比,术前有水肿的患者年龄明显偏大,淋巴结转移率和疾病分期明显偏高,控制营养状况(CONUT)评分和预后营养指数(PNI)明显偏低。与无术后水肿组相比,有术后水肿组的老年和女性患者比例明显更高,Billroth-II 重建率也更高。术后水肿组的细胞内水含量、全身水含量、蛋白质含量、骨骼肌质量和PNI也明显较低:结论:营养状况较差的老年患者会出现术前水肿,手术时间较短的老年患者会出现术后水肿。通过 BIA 评估的围手术期水肿状况被认为与围手术期营养状况有关。
{"title":"Factors Associated with Perioperative Edema in Patients with Stage I Gastric Cancer Using a Body Composition Analyzer.","authors":"Yuki Umetani, Keishiro Aoyagi, Hideaki Kaku, Yuya Tanaka, Taizan Minami, Taro Isobe, Junya Kizaki, Naotaka Murakami, Fumihiko Fujita, Yoshito Akagi","doi":"10.2739/kurumemedj.MS6934010","DOIUrl":"10.2739/kurumemedj.MS6934010","url":null,"abstract":"<p><strong>Purpose: </strong>Assessment of nutritional status and nutritional interventions is important in gastric cancer patients. We investigated the factors associated with perioperative edema in patients with stage I gastric cancer using a body composition analyzer.</p><p><strong>Methods: </strong>The study included 106 patients with stage I gastric cancer who underwent distal gastrectomy. The body composition of each patient was evaluated by bioelectrical impedance analysis (BIA) using an InBody 720 body composition analyzer. Patients with an extracellular water to total body water ratio of ≥ 0.4 before and 1 week after gastrectomy were considered to have edema, the cause of which was determined retrospectively.</p><p><strong>Results: </strong>Patients with preoperative edema were significantly older, had a significantly higher lymph node metastasis rate and disease stage, and had a significantly poorer Controlling Nutritional Status (CONUT) score, and Prognostic Nutritional Index (PNI) compared with patients without preoperative edema. The group with postoperative edema had significantly higher proportions of elderly and female patients as well as a higher rate of Billroth-II reconstruction compared with the group without postoperative edema. The group with postoperative edema also had significantly lower intracellular water content, total body water content, protein content, skeletal muscle mass, and PNI.</p><p><strong>Conclusions: </strong>Preoperative edema occurs in elderly patients with poor nutritional status, and postoperative edema occurs in elderly patients with a shorter operative time. Perioperative edema status assessed by BIA is thought to be related to perioperative nutritional status.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"201-208"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are the Ethmoidal Foramina Through the Frontal Bone, Ethmoid Bone, or Frontoethmoidal Suture? 乙状窦是通过额骨、乙状骨还是前牙窦缝?
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934012
Joe Iwanaga, Rishawn Dindial, Dany Hage, Mansour Mathkour, Marios Loukas, Jerzy A Walocha, Aaron S Dumont, R Shane Tubbs

Introduction: To investigate the locations of the anterior, middle, and posterior ethmoidal foramina and their relationships to the frontoethmoidal suture.

Methods: One hundred twenty sides from sixty adult human skulls were used. Specimens with significant damage to the medial orbit wall were excluded. The number of ethmoidal foramina (anterior, middle, and posterior) on the medial orbital wall and the relationship of each foramen to the frontoethmoidal suture were recorded and classified as follows: Type I: superior to the frontoethmoidal suture; Type II: on the frontoethmoidal suture; Type III: inferior to the frontoethmoidal suture.

Results: Of the ninety-four sides, fourteen (14.9%) had one foramen, sixty-two (66.0%) had two , and eighteen (19.1%) had three. In total, 192 ethmoidal foramina were observed. Among the fourteen sides with one foramen, eight foramina were anterior and six were posterior. Among the 192 ethmoidal foramina, 162 were eligible for fur ther classification (74 anterior, 14 middle, and 74 posterior). Types I, II, and III ethmoidal foramina were found in 38.3% (62/162), 61.7% (100/162), and 0% (0/162), respectively.

Conclusions: Our current study found a higher incidence of type I than previously reported. It is important to be aware of the significant incidence of foramen variations when the medial orbit wall is manipulated during surgery. Unless caution is observed, an inadvertent surgical injury can occur and lead to life-threatening complications. Therefore, a good understanding of orbital anatomy and its potential variations is critical for improving patient out comes.

内容简介研究乙状窦前、中、后孔的位置及其与前乙状窦缝的关系:方法:使用来自 60 个成人头骨的 120 个侧面。排除了内侧眶壁严重受损的标本。记录内侧眶壁上乙状孔(前、中、后)的数量以及每个乙状孔与额颞缝的关系,并将其分类如下:I型:在额蝶骨缝上方;II型:在额蝶骨缝上;III型:在额蝶骨缝下方:在九十四个侧面中,十四个(14.9%)有一个孔,六十二个(66.0%)有两个孔,十八个(19.1%)有三个孔。总共观察到 192 个乙状舌骨孔。在 14 个有一个孔的侧面中,8 个孔在前,6 个孔在后。在 192 个乙状孔中,有 162 个符合进一步分类的条件(74 个前方,14 个中间,74 个后方)。Ⅰ、Ⅱ和Ⅲ型乙状孔分别占 38.3%(62/162)、61.7%(100/162)和 0%(0/162):我们目前的研究发现 I 型的发生率高于之前的报道。在手术过程中操作内侧眶壁时,必须注意眶孔变异的显著发生率。除非小心谨慎,否则可能会发生意外手术损伤,导致危及生命的并发症。因此,充分了解眼眶解剖及其潜在的变化对于改善患者的预后至关重要。
{"title":"Are the Ethmoidal Foramina Through the Frontal Bone, Ethmoid Bone, or Frontoethmoidal Suture?","authors":"Joe Iwanaga, Rishawn Dindial, Dany Hage, Mansour Mathkour, Marios Loukas, Jerzy A Walocha, Aaron S Dumont, R Shane Tubbs","doi":"10.2739/kurumemedj.MS6934012","DOIUrl":"10.2739/kurumemedj.MS6934012","url":null,"abstract":"<p><strong>Introduction: </strong>To investigate the locations of the anterior, middle, and posterior ethmoidal foramina and their relationships to the frontoethmoidal suture.</p><p><strong>Methods: </strong>One hundred twenty sides from sixty adult human skulls were used. Specimens with significant damage to the medial orbit wall were excluded. The number of ethmoidal foramina (anterior, middle, and posterior) on the medial orbital wall and the relationship of each foramen to the frontoethmoidal suture were recorded and classified as follows: Type I: superior to the frontoethmoidal suture; Type II: on the frontoethmoidal suture; Type III: inferior to the frontoethmoidal suture.</p><p><strong>Results: </strong>Of the ninety-four sides, fourteen (14.9%) had one foramen, sixty-two (66.0%) had two , and eighteen (19.1%) had three. In total, 192 ethmoidal foramina were observed. Among the fourteen sides with one foramen, eight foramina were anterior and six were posterior. Among the 192 ethmoidal foramina, 162 were eligible for fur ther classification (74 anterior, 14 middle, and 74 posterior). Types I, II, and III ethmoidal foramina were found in 38.3% (62/162), 61.7% (100/162), and 0% (0/162), respectively.</p><p><strong>Conclusions: </strong>Our current study found a higher incidence of type I than previously reported. It is important to be aware of the significant incidence of foramen variations when the medial orbit wall is manipulated during surgery. Unless caution is observed, an inadvertent surgical injury can occur and lead to life-threatening complications. Therefore, a good understanding of orbital anatomy and its potential variations is critical for improving patient out comes.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"195-199"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Desaturation in Anesthetic Management During Airway Stenting. 气道支架植入术中麻醉管理中出现饱和度降低的风险因素。
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934003
Sakura Okamoto, Namie Somiya, Ran Hotta, Hideo Saka, Masahide Oki, Akira Tomita

Airway stenting involves a stent being inserted into a stenotic site in the airway. In patients with airway stenosis, the airway is the surgical field; therefore, anesthetic management is challenging, and avoiding hypoxia is important. Limited information is available on the anesthetic management of airway stenting. Risk factors for oxygen desaturation during airway stenting remain unknown. The present study was conducted to retrospectively examine patients who underwent airway stenting during a specific period and identify risk factors associated with oxygen desaturation. We performed univariate and multivariate analyses. The main evaluation items in a multivariate analysis were risk factors for desaturation (SpO2 ≤ 90%). Body mass index, preoperative orthopnea, the stenotic site of the airway, and severity of stenosis were selected for clinical usefulness. We analyzed 302 patients who underwent airway stenting at our hospital between July 2011 and June 2014 under general anesthesia with controlled ventilation. Total intravenous anesthesia with propofol target-controlled infusion and remifentanil was performed. Clinical data were extracted from electronic anesthetic records. The incidence of desaturation (SpO2 ≤ 90%) was 18.5% (56 out of 302 cases). Preoperative orthopnea (OR, 3.06)and stenosis distal to the bronchus (OR, 3.31) were identified as risk factors for desaturation in a multivariate analysis. We herein identified risk factors for desaturation during airway stenting. Anesthetic plans need to be carefully considered for patients with these risk factors.

气道支架植入术是将支架插入气道狭窄部位。对于气道狭窄患者,气道就是手术区域;因此,麻醉管理具有挑战性,避免缺氧非常重要。有关气道支架植入术麻醉管理的信息十分有限。气道支架植入术中出现氧饱和度降低的风险因素仍然未知。本研究旨在对特定时期内接受气道支架术的患者进行回顾性检查,并确定与氧饱和度降低相关的风险因素。我们进行了单变量和多变量分析。多变量分析的主要评估项目是血氧饱和度降低(SpO2 ≤ 90%)的风险因素。体质指数、术前呼吸矫治、气道狭窄部位和狭窄严重程度被选中用于临床。我们分析了 2011 年 7 月至 2014 年 6 月期间在我院接受气道支架手术的 302 名患者,他们都是在全身麻醉并控制通气的情况下接受手术的。采用异丙酚靶控输注和瑞芬太尼进行全静脉麻醉。临床数据来自电子麻醉记录。不饱和(SpO2≤90%)发生率为18.5%(302例中有56例)。在多变量分析中,术前呼吸暂停(OR,3.06)和支气管远端狭窄(OR,3.31)被确定为导致呼吸不饱和的风险因素。我们在此确定了气道支架植入术中出现不饱和的风险因素。对于存在这些风险因素的患者,需要仔细考虑麻醉计划。
{"title":"Risk Factors for Desaturation in Anesthetic Management During Airway Stenting.","authors":"Sakura Okamoto, Namie Somiya, Ran Hotta, Hideo Saka, Masahide Oki, Akira Tomita","doi":"10.2739/kurumemedj.MS6934003","DOIUrl":"10.2739/kurumemedj.MS6934003","url":null,"abstract":"<p><p>Airway stenting involves a stent being inserted into a stenotic site in the airway. In patients with airway stenosis, the airway is the surgical field; therefore, anesthetic management is challenging, and avoiding hypoxia is important. Limited information is available on the anesthetic management of airway stenting. Risk factors for oxygen desaturation during airway stenting remain unknown. The present study was conducted to retrospectively examine patients who underwent airway stenting during a specific period and identify risk factors associated with oxygen desaturation. We performed univariate and multivariate analyses. The main evaluation items in a multivariate analysis were risk factors for desaturation (SpO<sub>2</sub> ≤ 90%). Body mass index, preoperative orthopnea, the stenotic site of the airway, and severity of stenosis were selected for clinical usefulness. We analyzed 302 patients who underwent airway stenting at our hospital between July 2011 and June 2014 under general anesthesia with controlled ventilation. Total intravenous anesthesia with propofol target-controlled infusion and remifentanil was performed. Clinical data were extracted from electronic anesthetic records. The incidence of desaturation (SpO<sub>2</sub> ≤ 90%) was 18.5% (56 out of 302 cases). Preoperative orthopnea (OR, 3.06)and stenosis distal to the bronchus (OR, 3.31) were identified as risk factors for desaturation in a multivariate analysis. We herein identified risk factors for desaturation during airway stenting. Anesthetic plans need to be carefully considered for patients with these risk factors.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"135-142"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality-Adjusted Survival in Patients with Recurrence of Breast Cancer Diagnosed by Asymptomatic or Symptomatic Opportunities. 通过无症状或有症状机会确诊的乳腺癌复发患者的质量调整生存率
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934015
Kosho Yamanouchi, Shigeto Maeda

After radical surgery for breast cancer, screening to diagnose recurrence in asymptomatic patients is not recommended. We retrospectively evaluated quality-adjusted survival. Included were fifty-seven recurrent breast cancer patients who died. Survival was partitioned into 3 health states by two different definitions: definition a) time with toxicities due to chemotherapy before progression (TOX1), time from the diagnosis of recurrence to progression without toxicities (TWiST1), and time from progression to death (REL1); definition b) time from the diagnosis of recurrence to death with toxicities (TOX2), without toxicities or hospitalization (TWiST2), and with hospitalization (REL2). Q-TWiST was calculated by multiplying the time in each health state by its utility (uTOX, uTWiST, and uREL). In threshold analyses, uTOX and uREL ranged from 0.0 to 1.0 whereas uTWiST was maintained at 1.0. We compared the patients with (n=32) and without (n=25) symptoms at the time of the diagnosis of recurrence. There was no difference in overall survival after primary surgery, although survival after the diagnosis of recurrence was significantly longer in the asymptomatic patients (p<0.01). Q-TWiST1 and Q-TWiST2 from the diagnosis of recurrence in the asymptomatic patients were significantly longer. Q-TWiST2 from primary surgery in the asymptomatic patients was significantly longer with some combinations of higher uTOX2 and lower uREL2. In conclusion, the asymptomatic detection of recurrence was associated with significantly longer quality-adjusted survival in comparison to symptomatic detection with some combinations of uTOX2 and uREL2. A prospective evaluation would clarify adequate follow-up methods after radical surgery for breast cancer.

乳腺癌根治术后,不建议对无症状患者进行筛查以诊断复发。我们对质量调整生存率进行了回顾性评估。其中包括 57 名死亡的复发性乳腺癌患者。通过两种不同的定义将生存期划分为三种健康状态:定义 a)进展前化疗毒性反应时间(TOX1)、从诊断复发到无毒性反应进展时间(TWiST1)以及从进展到死亡时间(REL1);定义 b)从诊断复发到有毒性反应死亡时间(TOX2)、无毒性反应或住院时间(TWiST2)以及住院时间(REL2)。Q-TWiST 的计算方法是将每种健康状态下的时间乘以其效用(uTOX、uTWiST 和 uREL)。在阈值分析中,uTOX 和 uREL 的范围在 0.0 到 1.0 之间,而 uTWiST 则保持在 1.0。我们对诊断复发时有症状(32 人)和无症状(25 人)的患者进行了比较。尽管无症状患者在确诊复发后的生存期明显更长(p
{"title":"Quality-Adjusted Survival in Patients with Recurrence of Breast Cancer Diagnosed by Asymptomatic or Symptomatic Opportunities.","authors":"Kosho Yamanouchi, Shigeto Maeda","doi":"10.2739/kurumemedj.MS6934015","DOIUrl":"10.2739/kurumemedj.MS6934015","url":null,"abstract":"<p><p>After radical surgery for breast cancer, screening to diagnose recurrence in asymptomatic patients is not recommended. We retrospectively evaluated quality-adjusted survival. Included were fifty-seven recurrent breast cancer patients who died. Survival was partitioned into 3 health states by two different definitions: definition a) time with toxicities due to chemotherapy before progression (TOX1), time from the diagnosis of recurrence to progression without toxicities (TWiST1), and time from progression to death (REL1); definition b) time from the diagnosis of recurrence to death with toxicities (TOX2), without toxicities or hospitalization (TWiST2), and with hospitalization (REL2). Q-TWiST was calculated by multiplying the time in each health state by its utility (uTOX, uTWiST, and uREL). In threshold analyses, uTOX and uREL ranged from 0.0 to 1.0 whereas uTWiST was maintained at 1.0. We compared the patients with (n=32) and without (n=25) symptoms at the time of the diagnosis of recurrence. There was no difference in overall survival after primary surgery, although survival after the diagnosis of recurrence was significantly longer in the asymptomatic patients (p<0.01). Q-TWiST1 and Q-TWiST2 from the diagnosis of recurrence in the asymptomatic patients were significantly longer. Q-TWiST2 from primary surgery in the asymptomatic patients was significantly longer with some combinations of higher uTOX2 and lower uREL2. In conclusion, the asymptomatic detection of recurrence was associated with significantly longer quality-adjusted survival in comparison to symptomatic detection with some combinations of uTOX2 and uREL2. A prospective evaluation would clarify adequate follow-up methods after radical surgery for breast cancer.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"175-184"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brown-Kurume Exchange Programs Have Developed Through Many Unexpected Encounters and Relationships. 布朗-久留米交流计划是在许多意想不到的邂逅和关系中发展起来的。
Q4 Medicine Pub Date : 2024-05-14 Epub Date: 2024-01-16 DOI: 10.2739/kurumemedj.MS6934007
Emiko Mizoguchi

In July 1992, my 24 years of studying abroad in the US as a researcher at Harvard Medical School started. During this period, I met many outstanding scholars who conducted some of the world's leading research projects. In particular, the opportunity to collaborate with Dr. Jack A. Elias, Professor and Dean Emeritus of the Faculty of Medicine at Brown University, on a project focusing on a molecule called Chitinase 3-like 1 was very helpful to my career, and eventually led to my current position as Professor in charge of international medical exchange at Kurume University School of Medicine. By strengthening the foundation of our exchange programs and actively promoting international joint research projects, I would like to raise the global name recognition of Kurume University.

1992 年 7 月,我在美国哈佛大学医学院担任研究员的 24 年留学生活开始了。在此期间,我结识了许多杰出的学者,他们开展了一些世界领先的研究项目。特别是与布朗大学医学院名誉院长、教授杰克-埃利亚斯博士(Dr. Jack A. Elias)合作研究 "甲壳素酶 3-like 1 "分子的机会,对我的职业生涯帮助很大,并最终促成了我现在担任久留米大学医学院负责国际医学交流的教授一职。我希望通过加强交流项目的基础和积极推进国际联合研究项目,提高久留米大学在全球的知名度。
{"title":"Brown-Kurume Exchange Programs Have Developed Through Many Unexpected Encounters and Relationships.","authors":"Emiko Mizoguchi","doi":"10.2739/kurumemedj.MS6934007","DOIUrl":"10.2739/kurumemedj.MS6934007","url":null,"abstract":"<p><p>In July 1992, my 24 years of studying abroad in the US as a researcher at Harvard Medical School started. During this period, I met many outstanding scholars who conducted some of the world's leading research projects. In particular, the opportunity to collaborate with Dr. Jack A. Elias, Professor and Dean Emeritus of the Faculty of Medicine at Brown University, on a project focusing on a molecule called Chitinase 3-like 1 was very helpful to my career, and eventually led to my current position as Professor in charge of international medical exchange at Kurume University School of Medicine. By strengthening the foundation of our exchange programs and actively promoting international joint research projects, I would like to raise the global name recognition of Kurume University.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"119-126"},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kurume Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1